Question 1

How many institutions own APUS stock?

Accepted Answer

A company's 13F filings with the Securities and Exchange Commission (SEC) provides investors with comprehensive information about institutional ownership in a listed company, a sign of strength in terms of how many institutions have confidence in that company. The number of institutional investors who currently own APUS shares is 6, representing 2.97% of the company's common stock.

Question 2

Who are the major shareholders selling Apimeds Pharmaceuticals US, Inc stock?

Accepted Answer

JANE STREET GROUP, LLC, in the last quarter, reduced its stake in APUS by -100% restricting it's holding to 0 shares of worth nearly -. BANK OF AMERICA CORP /DE/ also lessened -100% of the APUS shares from its portfolio, reducing its holding to 0 shares of worth -. TOWER RESEARCH CAPITAL LLC (TRC) also shunned APUS shares holding by -100% last quarter which brought its holding to 0 shares worth -.

Question 3

Investors who are buying APUS stock?

Accepted Answer

As per its latest 13F filing, VANGUARD FIDUCIARY TRUST CO increased its stake in APUS by 100% in the last quarter. The institutional holder raised its holding to 24.04 thousand shares having worth more than $43.01K. TWO SIGMA SECURITIES, LLC also added 100% more shares of APUS to its portfolio, raising its holding to 10.55 thousand shares of worth $18.88K.  also increased its APUS shares holding by 100% which brought its holding to 95.93 thousand shares worth $171.62K.

Question 4

APUS's major insiders: who are they?

Accepted Answer

The insider with the most stakes in APUS is N/A , N/A at the company. Additionally, APUS stock is highly held by N/A N/A and N/A N/A among others.

Question 5

Did an insider recently sell APUS stock?

Accepted Answer

Company executives, directors, and other insiders own 52.58% percent of Apimeds Pharmaceuticals US, Inc's stock. Within the last six months, there have been 0 transaction(s) in which APUS insiders have sold stock, totaling 0 shares. Insiders that have sold shares include .

Question 6

Which insider recently purchased APUS stock?

Accepted Answer

There have been 0 transaction(s) during the past 6-months in which Apimeds Pharmaceuticals US, Inc insiders have bought stock, totalling 0 shares

Question 7

How much of APUS does insiders own?

Accepted Answer

Around 0 Apimeds Pharmaceuticals US, Inc shares are held by insiders, which represents about 52.58% of APUS stock.

Question 8

Who is the insider with the largest stake?

Accepted Answer

APUS N/A, N/A holds the largest portfolio of the company's shares. APUS shares owned by N/A total nearly -.

Question 9

Which institution holds the most shares in APUS?

Accepted Answer

VANGUARD FIDUCIARY TRUST CO is the largest institutional owner in APUS which holds 24.04 thousand shares worth $43.01K or 0.22% of the total APUS shares outstanding followed by TWO SIGMA SECURITIES, LLC with ownership of 10.55 thousand shares representing 0.1% of the APUS ownership. HEMENWAY TRUST CO LLC is the third largest stakeholder with 274 thousand shares or 2.52% of the ownership worth more than $490.30K.

Question 10

Is Apimeds Pharmaceuticals US, Inc stock optionable?

Accepted Answer

Stock options give the owner the ability but not the obligation to buy or sell a security at a predetermined price and date. Stock options can be classified into two types: puts and calls. A put is a bet on falling stock, and a call is a bet on rising stock. As far as the APUS is concerned, it is a stock which is not optionable.

Question 11

Is there a short position on APUS's shares?

Accepted Answer

Number of APUS shares short is null. Shares short is a market sentiment in which investors have sold their shares short in a given stock but have not yet covered them or closed them out.

Question 12

About how many outstanding APUS shares are there?

Accepted Answer

As of today, null shares of APUS are outstanding.

Question 13

Is there many float in APUS stock?

Accepted Answer

Float represents the number of tradeable shares in a specific stock. By subtracting restricted and closely-held shares from a firm's total outstanding shares, we can calculate its floating stock. The term "closely-held shares" refers to shares held by employees, major shareholders, and company insiders. At present, APUS has null shares in float.

Question 14

APUS short ratio: what is it?

Accepted Answer

Short ratio is calculated by dividing the number of short shares, short interest or bets that shareholders will sell short from the average daily volume. A higher ratio indicates longer times needed to repurchase borrowed shares (sold). The short ratio for APUS is null.

Date	Holder	% Stake	Shares Held	Total Value ($)	Shares	% Change in Portfolio
Mar 31, 2026	VANGUARD FIDUCIARY TRUST CO	0.22%	24.04K	43.01K	24.04K	+100.00%
Mar 31, 2026	TWO SIGMA SECURITIES, LLC	0.1%	10.55K	18.88K	10.55K	+100.00%
Mar 31, 2026	HEMENWAY TRUST CO LLC	2.52%	274K	490.3K	0	0
Mar 31, 2026		0.88%	95.93K	171.62K	95.93K	+100.00%
Mar 31, 2026	GEODE CAPITAL MANAGEMENT, LLC	0.37%	40.05K	71.67K	5.16K	+14.80%
Mar 31, 2026	JANE STREET GROUP, LLC	0%	0	-	-27.19K	-100.00%
Mar 31, 2026	BANK OF AMERICA CORP /DE/	0%	0	-	-40	-100.00%
Mar 31, 2026	TOWER RESEARCH CAPITAL LLC (TRC)	0%	0	-	-10	-100.00%
Mar 31, 2026	UBS GROUP AG	0.04%	4.19K	7.49K	3.61K	+619.42%

Date	Holder	% Stake	Shares Held	Total Value ($)	Shares	% Change in Portfolio
Mar 31, 2026	VANGUARD FIDUCIARY TRUST CO	0.22%	24.04K	43.01K	24.04K	+100.00%
Mar 31, 2026	TWO SIGMA SECURITIES, LLC	0.1%	10.55K	18.88K	10.55K	+100.00%
Mar 31, 2026	HEMENWAY TRUST CO LLC	2.52%	274K	490.3K	0	0
Mar 31, 2026		0.88%	95.93K	171.62K	95.93K	+100.00%
Mar 31, 2026	GEODE CAPITAL MANAGEMENT, LLC	0.37%	40.05K	71.67K	5.16K	+14.80%
Mar 31, 2026	JANE STREET GROUP, LLC	0%	0	-	-27.19K	-100.00%
Mar 31, 2026	BANK OF AMERICA CORP /DE/	0%	0	-	-40	-100.00%
Mar 31, 2026	TOWER RESEARCH CAPITAL LLC (TRC)	0%	0	-	-10	-100.00%
Mar 31, 2026	UBS GROUP AG	0.04%	4.19K	7.49K	3.61K	+619.42%

APUS Stock Ownership Breakdown

Apimeds Pharmaceuticals US

Stock Outstanding Shares

Market Insider

Institutional Ownership

Frequently Asked Questions

Stock Outstanding Shares

Market Insider

Institutional Ownership

Frequently Asked Questions